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Many therapies using mesenchymal stem cells (MSC) rely on their ability to produce
and release paracrine signals with chemotactic and pro-angiogenic activity. These
characteristics, however, are mostly studied under standard in vitro culture conditions.
In contrast, various novel cell-based therapies imply pre-seeding MSC into bio-artificial
scaffolds. Here we describe human bone marrow-derived MSC seeded in Integra
matrices, a common type of scaffold for dermal regeneration (SDR). We show and
measured the distribution of MSC within the SDR, where cells clearly establish physical
interactions with the scaffold, exhibiting constant metabolic activity for at least 15
days. In the SDR, MSC secrete VEGF and SDF-1α and induce transwell migration of
CD34+ hematopoietic/endothelial progenitor cells, which is inhibited in the presence
of a CXCR4/SDF-1α antagonist. MSC in SDR respond to hypoxia by altering levels of
angiogenic signals such as Angiogenin, Serpin-1, uPA, and IL-8. Finally, we show that
MSC-containing SDR that have been pre-incubated in hypoxia show higher infiltration
of endothelial cells after implantation into immune deficient mice. Our data show that
MSC are fully functional ex vivowhen implanted into SDR. In addition, our results strongly
support the notion of hypoxic pre-conditioning MSC-containing SDR, in order to promote
angiogenesis in the wounds.
Keywords: mesenchymal stem cells, scaffolds, wound healing, angiogenesis, hypoxia
INTRODUCTION
Skin is the largest organ of the body and is responsible for several critical functions, such as control
of body temperature and protection against external pathogens. Skin defects lead to the death of
thousands of people per year and represent large costs for the health care system. In this regard,
the development of scaffolds for dermal regeneration (SDR) has meant a significant breakthrough,
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especially for patients presenting large burns (Machens et al.,
2000). However, the clinical benefit of these scaffolds in chronic
wounds has been disappointing due to lack of induction of
dermal regeneration and re-epithelialization.We and others have
shown that SDR-mediated skin repair is greatly improved if SDR
are “bio-activated” by pre-implantation of cells (Markowicz et al.,
2006; Falanga et al., 2007; Egaña et al., 2009).
A very promising cell source for skin repair is mesenchymal
stem cells/multipotent stromal cells (MSC), which, in many
applications, do not contribute to regeneration through direct
differentiation into dermal, epithelial, or endothelial cells (tissue
replacement), but rather act as trophic mediators, releasing
chemotactic, immune modulatory, and pro-angiogenic factors
(Caplan and Dennis, 2006; Fu and Li, 2009). MSC are easy to
isolate from various tissue sources, including bone marrow and
adipose tissue (da Silva Meirelles et al., 2006), can be robustly
expanded ex vivo and present low immunogenicity, allowing
both autologous and allogeneic transplants (Uccelli et al., 2008).
Albeit an overall elusive function in vivo due to the absence
of specific MSC surface markers, MSC seem to correlate with
pericytes (Crisan et al., 2008). MSC from the bone marrow are
the primary source for osteo-progenitor cells and play a critical
role in supporting hematopoietic stem/progenitor cells (Sacchetti
et al., 2007). It has also been shown that direct intradermal
injection of human MSC promote wound healing in diabetic
mice (Kim et al., 2012; Shin and Peterson, 2013).
MSC that are expanded for in vitro studies are commonly
cultured in polystyrene plastic flasks or plates. The capability
to attach to plastic is indeed a major defining characteristic of
MSC (Dominici et al., 2006). However, parameters such as the
high stiffness of plastic strongly affect MSC cell fate (McBeath
et al., 2004; Engler et al., 2006), suggesting that characteristics
attributed to MSC will vary according to the specific in vitro
culture conditions. For example, when MSC cultured in three-
dimensional (3D) scaffolds are implanted into nude mice, they
generate more abundant and homogenous bone as compared to
MSC cultured asmonolayers (Braccini et al., 2005).MSC cultured
in 3D scaffolds respond to hypoxia by expressing higher levels of
the stem cell markers Oct-4 and Rex-1, and maintain a higher
colony forming unit (CFU-F) potential as compared to cells
in normoxia (Grayson et al., 2006). Hypoxia also enhances the
motility of MSC, improving their therapeutic potential on blood
flow restoration, as shown using a murine hind limb ischemia
model (Rosová et al., 2008). Finally, we have recently shown
that hypoxic pre-conditioning inducesmetabolic changes inMSC
that promote their retention after intramuscular injection into
immune deficient mice (Beegle et al., 2015).
This development suggests that combining scaffolds for
dermal regeneration (SDR) with MSC for the treatment of
chronic skin ulcers and wound repair would be an ideal
strategy. We recently compared incorporation of adipose-
tissue derived MSC into different scaffolds. In those studies,
parameters such as seeding efficiency, distribution, attachment,
survival, metabolic activity, and release of paracrine signals where
measured, where the best results were obtained with Integra™
matrices (Wahl et al., 2015). Integra™ Matrix Wound Dressing
is a bilayer scaffold composed of type I bovine collagen and
chondroitin-6-sulfate with a thin silicon layer. We have also
shown that Integra™ SDR seeded with a mesenchymal cell line
show a strong increase of new blood vessel formation, following
a skin wound excision model in nude mice (Egaña et al., 2009).
These results strongly support the strategy of “bio-activating”
Integra™ SDR by pre-seeding it with MSC.
Here we show that bone marrow-derived MSC implanted
in three dimensional SDR promote key features for wound
repair applications, such as sustained viability, migration
of hematopoietic/endothelial progenitor cells (H/EPC) and
response to hypoxia, inducing release of pro-angiogenic signals
in vitro. Most importantly, our results also suggest that pre-
incubation with hypoxia increases the angiogenic potential of
MSC/SDR in vivo.
MATERIALS AND METHODS
Cell Isolation and Culture
MSC were obtained from either bone marrow samples of
healthy human donors who gave informed consent to the
research protocols (approved by the institutional review board
of the Technical University of Dresden) or purchased from
Allcells (Alameda, CA). Mononuclear cell (MNC) fraction of
bone marrow aspirates were obtained by density gradient
centrifugation [Percoll (1.073 g/l) for 30min at 700 × g] and
plated in plastic culture flasks with MSC culture media (see
below). After 3 days, non-adherent cells were removed by 2–3
washing steps with PBS. MSC culture media used for viability
assays, secretion of VEGF and SDF-1α and migration assays
was low glucose (1 g/L) Dulbecco’s modified Eagle’s medium
(DMEM; Invitrogen, Carlsbad, CA) supplemented with 10%
fetal bovine serum (FBS; Biochrom AG, Berlin, Germany). MSC
culture media used for confocal imaging in SDR, analysis of
distribution, hypoxia-induced angiogenic proteome array and
in vivo studies was MEM-alpha (HyClone Thermo Scientific,
WalthamMA) supplemented with 10% FBS (Atlanta Biologicals,
Lawrenceville GA). In all cases, MSC from passages 2–6 where
used for experimentation. All MSC are routinely characterized
for immune phenotype (CD14−, CD34−, CD45−, CD73+,
CD90+, CD105+, and CD166+) and differentiation potential
into both adipocytes and osteoblasts (not shown).
For isolation of CD34+ cells, leukapheresis samples were
obtained from healthy donors, whose stem cells were mobilized
by administration of GM-CSF, following institutional approval.
MNC were separated by density gradient [centrifugation over
Percoll (1.073 g/l) 30min at 700 × g]. CD34+ cells were
isolated using anti-CD34 coated paramagnetic microbeads
according to manufacturer instructions (Miltenyi, Begisch-
Gladbach, Germany).
Seeding MSC in SDR
For all experiments performed with MSC in SDR (Integra™
Matrix Wound Dressing; Plainsboro, NJ), the following protocol
was used: Pieces of SDR matrices (10mm diameter, approximate
volume; 0.3 cm3) were dried with sterile gauze, placed in 24-
well plates and 2.5 × 105 MSC in 300µl culture medium were
dropped over the scaffold and quickly absorbed. After 30min of
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incubation in the cell culture hood, 1ml of culture media was
added to each well.
Imaging of SDR by Scanning Electron
Microscopy
For scanning electron microscopy of SDR, scaffolds were washed
with PBS and fixed with 2% glutaraldehyde for 1 h at room
temperature and then overnight at 4◦C. SDR were dehydrated
in a series of acetone (30–100%) and critical-point-dried in a
CO2 system (Critical Point Dryer CPD 030, BAL-TEC GmbH,
Witten, Germany). Samples were then sectioned andmounted on
aluminum stubs and sputter-coated with gold (Sputter Coating
Device SCD 050, BAL-TEC GmbH, Witten, Germany). Finally,
samples were analyzed at 10 kV accelerating voltage in an
environmental scanning electron microscope (XL 30; Philips,
Eindhoven, The Netherlands).
Imaging of MSC in SDR by Laser Scanning
Confocal Microscopy
For the observation of MSC in SDR, the following protocol
was followed: 3 days after seeding MSC in SDR, scaffolds
containing cells were rinsed with PBS, fixed for 30min with
paraformaldehyde (3.7% paraformaldehyde, 0.1% Triton in PBS),
and blocked in 2% BSA in PBS prior to incubation in phalloidin-
texas red to stain actin and To-Pro3 to stain DNA. After washing,
scaffolds were imaged using a confocal microscope to assess the
number of cells that were seeded, the distribution of cells and
their morphology. Three SDR were examined, and each of which
was seeded using MSC derived from three different donors.
Since Integra™ Matrix was ∼1mm in thickness, the matrices
were sectioned, turned on their sides and z-section image series
acquired (about 100µm z-sect depth). Seven sections were
imaged and analyzed so as to gather a representative sampling.
Fluorescence imaging of cells upon and within the matrix
were optimized so as to avoid spectral overlap since collagen
was observed to auto-fluorescence in UV and FITC channels
(emission ranging over 300–500 nm).
Cell Loading Capacity and Cell Retention
In SDR
MSC cultured in SDR for up to 15 days were incubated
for 3 h in fresh medium containing 5 ng/ml of MTT (3-(4,5-
dimethyl-2-Thiazolyl)-2,5-Diphenyl-2H-Tetrazolium bromide)
(Sigma-Aldrich, Turkirchen, Germany). Then, medium was
removed and replaced by 300µl dimethyl sulfoxide (DMSO).
After 15min incubation, DMSO was removed and absorbance
was measured at 570 nm to quantify formation of formazan blue,
which is proportional to the number of living cells. Scaffolds
without cells were used as negative control.
VEGF and SDF-1α Release from MSC in
SDR
Two days after seeding MSC in SDR, medium was replaced with
DMEM + 2% FBS. Then, every 48 h medium was removed and
replaced with fresh medium. VEGF and SDF-1α concentrations
were measured by ELISA according to manufacturer instructions
(Quantikine ELISA kits, R&D systems, Minneapolis, MN).
Scaffolds without cells were used as negative controls.
Migration Assay
2 × 105 CD34+ cells in 100µl RPMI were added into inserts
of 5µm-pore transwell plates (Corning Inc., Corning, NY) with
conditioned media of MSC-containing SDR or empty SDR
(control) in the lower compartment. After incubation for 4 h,
inserts were removed and cells that migrated into the lower
compartment were counted using Trypan blue exclusion dye and
a hemocytometer. The effect of blocking the CXCR4 receptor
was evaluated by pre-incubation of the cells for 2 h in media
containing 100µMAMD3100 (Sigma).
Angiogenesis Proteome Array
MSC derived from three different donors were seeded in SDR
as described above. After 24 h, medium was changed to MEM-
alpha + 2% FBS and cells cultured for 48 h either under normal
(21% O2) or hypoxic (3% O2) conditions. Next, media were
collected and used in a Proteome Profiler Human Angiogenesis
Array Kit, following manufacturer instructions (R&D Systems).
Hypoxia was generated in an incubator at 37◦C with 5% CO2
humidified atmosphere and dedicated oxygen level (3% O2), as
established by replacement with Nitrogen injections.
Endothelial Cell Migration in a Wound
Excision Model in vivo
All animal procedures were performed strictly adhering to
protocols approved by the Institutional Animal Care and Use
Committee at UC Davis. Two excisional wounds were generated
bilaterally on the flanks of immune deficient NOD/SCID
IL2Rγ –/– (NSG) mice, as previously described (Egaña et al.,
2009; Schenck et al., 2014). Briefly, animals were placed under
anesthesia (1.5–3% isoflurane), fur was shaved and an area of skin
was removed on both the left and/or right flank of the animal
using a 10mm biopsy punch. Then, a 15mm piece of surgical
mesh (TiMESH Titanized Polymers, Nuernberg, Germany) was
placed under the wound edge, thus covering the wound bed.
Next, an 8–10mm piece of SDR was placed over the wound
bed. Each condition, (SDR alone or SDR containing MSC pre-
incubated for 2 days in either 21 or 3% O2) was placed bilaterally
into 3 animals for a total of 6 replicates. SDRwere fixed at 6 points
with skin glue (Histoacryl Topical Skin Adhesive, TissueSeal,
Ann Arbor, MI), such that the wound edge overlapped 1–2mm
with the scaffold. Finally, wounds were covered with sterile gauze
and adhesive tape and monitored daily.
After 14 days, animals were euthanized and SDR with
surrounding tissue processed for histological analysis. Samples
were transferred to a blocking solution (2% BSA in PBS)
at room temperature for 2 h. Then, tissues were blotted dry
with gauze and incubated in PBS containing 0.5% Triton X-
100 and a 1:75 dilution of Biotinylated GSL I—isolectin B4
(Vector Laboratories, Burlingame, CA), was applied at room
temperature for 1 h with gentle agitation on a platform shaker.
GSL I—isolectin B4 has been shown to recognize terminal α-
galactosyl residues found on the glycoprotein laminin secreted
by endothelial cells while forming the basal lamina of blood
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vessels (Benton et al., 2008). After washing 3 times for 5min each
with PBS containing 0.5% Triton X-100, Dylight 649-streptavidin
secondary antibody (Vector Labs) at a 1:150 dilution was applied
at room temperature for 1 h with shaking. After 3 additional
washes with PBS + 0.5% Triton X-100 and a final wash with
PBS, samples were mounted in VectaShield containing DAPI
(Vector Labs). Imaging was done on an Olympus FluoView
FV10i confocal microscope. Each sample was cut into up to four
sections and each cut was placed on its cross-section for imaging.
At least 35 images per condition were analyzed and averaged for
the quantification of endothelial cell infiltration.
Statistical Analysis
All assays were repeated in at least three independent
experiments. Results are expressed as averages with the standard
error of the mean (SEM) as error bars, unless otherwise stated.
One-Way ANOVA or Student’s t-tests were used to compare
samples, where p < 0.05 was considered significantly different.
RESULTS
To characterize MSC cultured in SDR, we first used scanning
electron microscopy (SEM) to inspect the scaffold. We observed
that the SDR has a randomly folded laminar structure, which
generates large spaces of 50–200µm in diameter (Figure 1A).
To evaluate how MSC distribute within this scaffold, we seeded
the MSC in SDR and cultured them for 3 days to allow
maximum attachment and spreading within the scaffold. Then,
samples were fixed and examined using confocal imaging. We
counted cell nuclei within each z-section image and tabulated
their distribution with respect to the scaffold fraction. Although
cell distribution appeared relatively homogenous within the
scaffold (Figure 1B), 85% of cells were found concentrated in
the upper half of the scaffold (Figures 1C,D). Also using this z-
stack analysis, we inferred an average seeding efficiency of 92%.
MSC were observed to be well spread throughout the matrix as
evidenced by actin staining (Figures 1B,C).
Next we quantified cell load-capacity of SDR using a MTT
assay. First, we demonstrate that there was no unspecific labeling
with MTT substrate in empty scaffolds. In contrast, MSC-
containing scaffolds show cells turning a dark blue color, which
can be clearly visualized using microscopy (Figure 2A). Next, we
seeded increasing doses of MSC and concluded that the SDR
supports high cellularity, with the highest concentration tested
equated to 3.6 × 106 cells per 1 cm2 (Figure 2B). To evaluate
whether MSCs were viable and if they proliferate within the
SDR matrix, we cultured the cells for up to 15 days. As shown
in Figure 2C, we found constant formazan blue formation,
suggesting that MSC are viable and metabolically stable within
the scaffold for at least 15 days, but show limited expansion.
FIGURE 1 | SDR topology and distribution of MSC in them. (A) SDR as observed using scanning electron microscopy (SEM). SDR has a randomly folded laminar
structure, which generates large spaces of 50–200mm in diameter. (B–D) 2.5× 105 MSC were seeded in SDR, cultured for 3 days to allow maximum attachment and
spreading, and fixed for staining as follows: Nuclei were stained with DAPI (blue), actin cytoskeleton is labeled with TRITC-coupled phalloidin and auto-fluorescence of
SDR is shown in green. Although cell distribution appears relatively homogenous within the scaffold surface, 85% of cells were found concentrated in the upper half of
the scaffold (C,D). To quantify cell distribution, cell nuclei were counted within each z-section image and their distribution tabulated with respect to the scaffold
fraction. Also using this z-stack analysis, we inferred an average seeding efficiency of 92%. Scale bar represents 0.1µm in (A), 50µm in (B), and 500µm in (C).
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FIGURE 2 | Cell load capacity and cellular viability within SDR matrices. (A) MTT assay on empty- and MSC-containing SDR matrix demonstrates specific
formazan formation by cells (dark blue). (B) MSC were seeded in 0.13 cm2 pieces of SDR matrix and cultured for 24 h to allow maximum spreading and adhesion of
cells. Then, scaffolds with cells were incubated with MTT substrate to determine relative cellularity based on formazan blue formation. (C) MSC in SDR matrices
shows relatively constant MTT hydrolysis for up to 15 days. Scale bars represent 200µm.
FIGURE 3 | MSC-containing SDR secrete VEGF, SDF-1α, and induce migration of CD34+ H/EPC in vitro. (A) MSC-containing SDR were incubated with
medium changes every second day. At every medium change, supernatants were collected, and VEGF and SDF-1α protein levels measured by ELISA. Average of
MSC from 3 different donors are shown. (B) Supernatant of SDR (control) and SDR + MSC were collected after 48 h incubation and tested for CD34+ H/EPC
migration in a transwell assay, as described in the Materials and Methods Section. In addition, AMD3100 (100 ng/ml) was added to the SDR + MSC condition during
the transwell assay. Average of CD34+ of 3 different donors using MSCs from 2 different donors are shown. *p < 0.05.
In the following set of experiments, we determined whether
the SDR could be “bio-activated” with MSC in terms of secreting
functionally relevant levels of chemotactic and angiogenic
signals. The development of new vasculature during the tissue
repair process is driven by two major mechanisms: angiogenesis
and vasculogenesis (Carmeliet, 2000). While the latter implies
the recruitment of new endothelial progenitor cells (EPC),
angiogenesis is commonly defined as the extension of pre-
existing blood vessels and is therefore dependent on the
proliferation and organization of endothelial cells (Carmeliet,
2000). Vascular remodeling (vasculogenesis) relies on the
recruitment of CD34+ EPC (Asahara et al., 1997). Since EPC
mobilization and homing to the site of injury depends on the
CXCR4/SDF-1α axis (Tachibana et al., 1998; Moore et al., 2001),
we tested whether MSC-containing scaffolds could produce and
release significant levels of SDF-1α. For this, MSC were seeded
in SDR matrix, medium was changed every second day and SDF-
1α protein levels were measured in the collected supernatant by
ELISA. As shown in Figure 3A, SDF-1α levels are low for the
first 2 days after seeding MSC in SDR. However, constant levels
(ranging from 1.3 to 1.7 ng/ml) of SDF-1α were detected from
days 4 to 14. Most importantly, MSC-containing scaffolds are
capable of inducing migration of CD34+ cells (comprising both
hematopoietic- and endothelial- progenitor cells (H/EPC) in a
transwell-migration assay, demonstrating that the chemotactic
signals released are fully functional. Furthermore, the migration
of CD34+ cells was partially inhibited by the CXCR4 antagonist
AMD3100, strongly suggesting that the migration of CD34+ cells
is at least partly due to SDF-1α released by MSC-containing SDR
(Figure 3B).
As shown in Figure 3A, MSC-containing SDR also release
constant levels of the angiogenic signal vascular endothelial
growth factor (VEGF) (2.2 + 0.5 ng/ml). In addition, we tested
whether MSC are able to respond to hypoxia when seeded in
SDR. For this, seeded scaffolds were cultured for 48 h in the
presence of either 21% (normoxia) or 3%O2 (hypoxia). As shown
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FIGURE 4 | MSC-containing SDR secrete angiogenic factors and respond to hypoxia. MSC-containing SDR were cultured under normoxic or hypoxic
conditions for 2 days and supernatant collected for angiogenic factors as described in Section Materials and Methods. (A) Representative angiogenesis-proteome
array. (B) Quantification of angiogenesis proteome array, using MSC from 3 different donors. *p < 0.05; **p < 0.005.
in Figures 4A,B, several angiogenic signals could be detected
in supernatants of MSC-seeded SDR. Among them, angiogenin
(Ang), and interleukin 8 (IL-8) were significantly up-regulated
during hypoxia, while serpin-1 and urokinase-type plasminogen
activator (uPA) protein levels were strongly inhibited by hypoxia.
Finally, we tested whether MSC-seeded SDR pre-incubated
for 48 h in hypoxia would exert a functional effect in vivo. For
this we generated bilateral excisional full skin defects in mice
and implanted in each either SDR alone or MSC-containing
SDR that were pre-incubated for 2 days in either normoxic or
hypoxic conditions. Figure 5 shows both representative images
and the quantification of endothelial cells in the wound area that
were secreting the specific glycoform of laminin found in the
basal lamina of blood vessels, 14 days after surgery. Previous
studies have shown that GSLI-isolectin B4 labels only the basal
lamina of blood vessels secreted by endothelial cells within the
dermal layers (Brabec et al., 1980; Benton et al., 2008). While
no significant differences were found between SDR alone and
MSC-containing SDR in normoxia, pre-incubation for 2 days
in hypoxia had a highly significant effect promoting endothelial
cell migration into wound edge, suggesting that hypoxic pre-
conditioning is essential for promoting blood vessel formation in
MSC-containing SDR.
DISCUSSION
The reparative potential of skin is limited because wounds
are typically replaced by scar formation, which restores tissue
integrity, but not full functionality. This is critical in massive
(e.g., burns) and specific (e.g., neck, hands, elbows) skin injuries
where functional tissue is required. In this context, SDR have
been used as templates to favor a skin regeneration process.
However, an important limitation in efficacy of SDR to induce
tissue regeneration is the lack of proper vascularization. This
limitation could be circumvented by “bio-activating” the SDR
with MSC, which are able to induce angiogenesis and recruit
H/EPC via secretion of paracrine factors. Nevertheless, these
properties of MSC have been studied in vitro under standard
culture conditions, where cells are grown as monolayers adhered
to plastic. In contrast, little is known about their performance in
3D structures. SDR provide a very different cell culture condition,
generating several local microenvironments and gradients, which
may influence the exocrine profile of MSC, as well as their
proliferation and survival, among others.
Ultra-structural characterization of the SDR used in this
study (Integra™ Matrix Wound Dressing) revealed 50–200µm
diameter pores within the scaffold. Of note, during the
preparation process, the SDR was dried, possibly altering the
fine structure morphology of the matrix. Commercially, this
SDR is stabilized with glutaraldehyde and stored in sodium
phosphate buffer. However, our images show a structure that
allows a homogenous distribution of MSC, as observed by
confocal microscopy. Of note, a key step in our protocol is
the seeding process: if MSC are seeded into wet scaffolds, cells
stay attached in higher densities at the surface of the SDR (not
shown), presumably due to a high affinity of MSC to attach to
collagen (Cool and Nurcombe, 2005). In contrast, slightly drying
the SDR with subsequent addition of highly concentrated MSC
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FIGURE 5 | Hypoxic pre-conditioning of MSC-containing SDR favors
high cellular infiltration in vivo. MSC-containing SDR were cultured under
normoxic or hypoxic conditions for 2 days and then implanted into immune
deficient NSG mice, following a skin excision procedure. After 2 weeks,
animals were euthanized and scaffold and surrounding tissue were analyzed
using laser scanning confocal microscopy. (A) Green shows the SDR (due to
auto-fluorescence of collagen), blue shows DAPI staining of cell nuclei, and red
shows the staining of GSLI isolectin B4 which binds to the terminal
α-D-galactosyl residues of the glycoprotein laminin (GP) expressed by
endothelial cells within the basal lamina of neovascular structures. The white
line indicates the border of the scaffold and surrounding tissue. (B)
Quantification of endothelial cells (ECs), as determined by the average number
of GP-positive cells within the first 200µm of SDR near wound edge. Scale
bar represents 50µm. *p < 0.05.
(∼1000 cells/µl) promotes absorption of the cells into the SDR,
favoring the penetration of cells into the scaffold. Addition of
more culturemedia 20–30min later ensures optimalMSC culture
conditions. Our distribution analysis reveals that 85% of cells are
concentrated in the upper half of the scaffold, suggesting that for
clinical applications, the MSC-containing SDR should be placed
with the upper side facing toward the wound, in order to favor
the interaction of MSC with surrounding tissue. Alternatively,
MSC could be seeded from both sides to further increase the total
amount of cells incorporated. Direct interaction of MSC in the
SDR was demonstrated as cells attached and spread, acquiring
characteristic fibroblastic morphology. The adhesion of MSC is
critical, since detachment of cells induces programmed cell death,
a process known as anoikis (Frisch and Francis, 1994).
The notion that MSC attached to the scaffold remain viable
is supported by detection of constant formazan formation. Our
results also suggest that MSC may not extensively proliferate
under these culture conditions. This is further supported by the
steady levels of secreted SDF-1α and VEGF reached by 2–4 days
after seeding. The proliferation of MSC could be limited due to a
rather low volume of culture media added to each scaffold/well,
limiting nutrient availability. Alternatively, integrin-mediated
adhesion of MSC to the matrix may inhibit cell proliferation
(Giancotti and Ruoslahti, 1999). The constant release of factors
such as VEGF and SDF-1α could possibly have an important
impact on the regeneration process. VEGF is a potent mitogen
for endothelial cells and induces endothelial cell migration,
sprouting, and survival (Ozawa et al., 2004). The CXCR4/SDF-
1α axis is essential for stem cell homing and mobilization into
damage tissues (Tachibana et al., 1998; Peled et al., 1999; Ceradini
et al., 2004). Of note, SDF-1α has been shown to improve wound
healing in diabetic mice (Badillo et al., 2007).
Here we show that MSC seeded in SDR respond to hypoxia,
which alters their expression of angiogenic factors.We found that
MSC in SDR under hypoxia increase Ang and IL-8 secretion.
This effect has been reported in various cell types, including
MSC cultured under standard conditions (Hung et al., 2007;
Potier et al., 2007). Ang is an important RNAse that promotes
neovascularization. When new vessels are required, Ang is
incorporated into endothelial cells and transferred to their nuclei.
There, it stimulates rRNA transcription, a rate-limiting step
in ribosome biogenesis, protein translation, and cell growth
(Wiedlocha, 1999; Tello-Montoliu et al., 2006). It has also been
shown that angiogenin is necessary for angiogenesis induced by
factors such as VEGF (Kishimoto et al., 2005). Expression of
the chemokine IL-8 directly correlates with neovascularization
(Yoneda et al., 1998) by stimulating both proliferation and
migration of endothelial cells (Brat et al., 2005). We hypothesize
that the observed reduction of PAI-1 and uPA under hypoxia
are inter-related events, because interaction of PAI-1 with the
uPA/uPA-receptor complex induces internalization of the ternary
complex uPA-R/uPA/PAI-1, resulting in degradation of uPA and
PAI-1, while uPA-R is recycled to the cell surface (Harbeck
et al., 2004). According to our angiogenesis array, hypoxia
only induced a modest increase in VEGF levels in MSC in
SDR. However, using ELISA, we and others have observed
that expression of VEGF is significantly increased in MSC
under hypoxia (not shown). This is most likely due to limited
sensitivity of the angiogenesis array, where VEGF detection
approached saturation levels (maximal pixel intensity). The
angiogenesis array is only a semi-quantification based on pixel
intensity of the dots, rather than colorimetric optical density,
with quantification based on a standard curve, as used in
ELISAs.
The exocrine effects of MSC could have tremendous impacts
on the development of new strategies to enhance vascularization
and tissue regeneration in tissue engineering approaches. The
use of MSC seeded scaffolds should be studied in massive or
chronic wounds in in vivo settings. Indeed, our in vivo studies
strongly support the notion that hypoxic pre-conditioning favors
the infiltration of endothelial cells into the wound bed that are in
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the early stages of neovascularization. The mechanism, however,
remains unclear. One possibility is that hypoxic pre-conditioning
enhances the survival of MSC after implantation, hence a greater
number of endothelial cells is favored by increased presence of
MSC (Beegle et al., 2015). Alternatively, hypoxia increases the
secretion of angiogenic signals (as shown in vitro) that promote
endothelial cell migration. These and other hypotheses need
future experimental validation. In addition, future studies need
to directly address the effect of hypoxic MSC-containing SDR in
wound closure.
This work underlines the relevance of studying MSC not only
under standard culture conditions, but also in environments
that more closely mimic their potential clinical application.
Our results suggest that seeding MSC into SDR potentially
“bio-activates” the material to enhance the regenerative
process. Finally, we show that hypoxic-preconditioning of
MSC-containing SDR has a strong positive impact promoting
endothelial cell infiltration toward the wound bed, possibly
contributing the wound repair process.
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